Search research articles
Contact Us
Filters
Showing results (251-260 of 371) with videos related to
Page
of 38
Sort By:
Geburtshilfe Und Frauenheilkunde
|
April 6, 2023
Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)
Clemens Tempfer, Lars-Christian Horn, Sven Ackermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
Determining the axillary nodal status with four current imaging modalities including <sup>18</sup>F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard
Janna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.
Clinical Chemistry
|
October 1, 2014
Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer
Rui P L Neves, Katharina Raba, Oliver Schmidt, et al.
Breast Care (Basel, Switzerland)
|
November 1, 2021
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet
Cornelia Kolberg-Liedtke, Rachel Wuerstlein, Oleg Gluz, et al.
The Lancet. Oncology
|
May 2, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial
Tanja Fehm, Francesco Cottone, Kyle Dunton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 16, 2015
The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study
Christina Fotopoulou, Jalid Sehouli, Nina Ewald-Riegler, et al.
International Journal of Cancer
|
June 2, 2025
Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients
Kathrin Niedermayer, Henning Schäffler, Georgios Vlachos, et al.
Journal of the National Cancer Institute
|
May 17, 2014
Circulating tumor cells predict survival in early average-to-high risk breast cancer patients
Brigitte Rack, Christian Schindlbeck, Julia Jückstock, et al.
Acta Neuropathologica Communications
|
May 3, 2025
Identification and characterization of tertiary lymphoid structures in brain metastases
Sadaf S Mughal, Yvonne Reiss, Jörg Felsberg, et al.
Geburtshilfe Und Frauenheilkunde
|
June 25, 2026
Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025
Beyhan Ataseven, Marco Battista, Matthias W Beckmann, et al.
Page
of 38
Search research articles
Search
Showing results (251-260 of 371) with videos related to
Sort By:
Page
of 38
Geburtshilfe Und Frauenheilkunde
|
April 6, 2023
Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022)
Clemens Tempfer, Lars-Christian Horn, Sven Ackermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
Determining the axillary nodal status with four current imaging modalities including <sup>18</sup>F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard
Janna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.
Clinical Chemistry
|
October 1, 2014
Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer
Rui P L Neves, Katharina Raba, Oliver Schmidt, et al.
Breast Care (Basel, Switzerland)
|
November 1, 2021
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet
Cornelia Kolberg-Liedtke, Rachel Wuerstlein, Oleg Gluz, et al.
The Lancet. Oncology
|
May 2, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial
Tanja Fehm, Francesco Cottone, Kyle Dunton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 16, 2015
The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study
Christina Fotopoulou, Jalid Sehouli, Nina Ewald-Riegler, et al.
International Journal of Cancer
|
June 2, 2025
Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients
Kathrin Niedermayer, Henning Schäffler, Georgios Vlachos, et al.
Journal of the National Cancer Institute
|
May 17, 2014
Circulating tumor cells predict survival in early average-to-high risk breast cancer patients
Brigitte Rack, Christian Schindlbeck, Julia Jückstock, et al.
Acta Neuropathologica Communications
|
May 3, 2025
Identification and characterization of tertiary lymphoid structures in brain metastases
Sadaf S Mughal, Yvonne Reiss, Jörg Felsberg, et al.
Geburtshilfe Und Frauenheilkunde
|
June 25, 2026
Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025
Beyhan Ataseven, Marco Battista, Matthias W Beckmann, et al.
Page
of 38